HPS Pharmacies wish to advise that Amdipharm Mercury Australia is experiencing a supply interruption for Apresoline® Ampoules as follows:

Apresoline® Ampoules
Hydralazine hydrochloride 20mg
ARTG 43190

Normal supplies are expected to resume by the end of March 2026.

While an internationally registered alternative has been approved for supply under Section 19A of the Therapeutic Goods Act 1989, this product is not yet available.

Hydralazine ampoules can currently only be accessed via the Special Access Scheme (SAS).

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Amdipharm Mercury Australia on 1800 627 680, or your pharmacist at HPS Pharmacies.

 

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates